Veeva Systems (VEEV) Hits New 1-Year High and Low at $79.15

Veeva Systems (NYSE:VEEV)’s share price reached a new 52-week high and low during trading on Monday . The stock traded as low as $79.15 and last traded at $77.79, with a volume of 29118 shares changing hands. The stock had previously closed at $78.28.

Several equities analysts recently commented on VEEV shares. Morgan Stanley raised shares of Veeva Systems from an “equal weight” rating to an “overweight” rating in a report on Tuesday, January 30th. DA Davidson started coverage on shares of Veeva Systems in a report on Friday, February 2nd. They set a “buy” rating and a $75.00 target price on the stock. Zacks Investment Research lowered shares of Veeva Systems from a “hold” rating to a “sell” rating in a report on Friday, February 2nd. Vetr raised shares of Veeva Systems from a “buy” rating to a “strong-buy” rating and set a $61.05 target price on the stock in a report on Thursday, February 8th. Finally, William Blair reaffirmed an “outperform” rating on shares of Veeva Systems in a report on Wednesday, February 21st. Five investment analysts have rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company’s stock. Veeva Systems presently has an average rating of “Buy” and an average target price of $72.23.

The stock has a market cap of $10.98 billion, a price-to-earnings ratio of 83.42, a price-to-earnings-growth ratio of 4.67 and a beta of 1.40.

Veeva Systems (NYSE:VEEV) last announced its quarterly earnings results on Tuesday, February 27th. The technology company reported $0.17 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.15 by $0.02. The business had revenue of $184.92 million during the quarter, compared to analysts’ expectations of $180.13 million. Veeva Systems had a net margin of 20.71% and a return on equity of 11.89%. equities research analysts anticipate that Veeva Systems will post 0.98 EPS for the current year.

In other news, CFO Timothy S. Cabral sold 40,000 shares of the firm’s stock in a transaction dated Wednesday, March 7th. The shares were sold at an average price of $77.01, for a total value of $3,080,400.00. Following the completion of the sale, the chief financial officer now directly owns 30,000 shares of the company’s stock, valued at approximately $2,310,300. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Alan Mateo sold 603 shares of the firm’s stock in a transaction dated Monday, April 16th. The stock was sold at an average price of $72.59, for a total transaction of $43,771.77. Following the completion of the sale, the executive vice president now directly owns 11,221 shares of the company’s stock, valued at $814,532.39. The disclosure for this sale can be found here. Insiders have sold a total of 181,733 shares of company stock valued at $13,411,000 in the last three months. 15.97% of the stock is currently owned by corporate insiders.

Several large investors have recently bought and sold shares of VEEV. Cerebellum GP LLC purchased a new position in Veeva Systems during the 4th quarter valued at about $129,000. American International Group Inc. purchased a new position in Veeva Systems during the 4th quarter valued at about $142,000. Northwestern Mutual Wealth Management Co. lifted its position in Veeva Systems by 154.3% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,176 shares of the technology company’s stock valued at $176,000 after acquiring an additional 1,927 shares during the period. Synovus Financial Corp purchased a new position in Veeva Systems during the 1st quarter valued at about $201,000. Finally, Azimuth Capital Management LLC purchased a new position in Veeva Systems during the 1st quarter valued at about $204,000. 73.84% of the stock is owned by hedge funds and other institutional investors.

Veeva Systems Company Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, and internationally. The company offers Veeva Commercial Cloud, a suite of multichannel customer relationship management applications, which allow pharmaceutical and biotechnology companies to target and support sales and marketing to physicians, other healthcare professionals, and healthcare organizations through various touch points, including in-person, email, and online; and Veeva Vault, a cloud-based enterprise content management platform and suite of applications for managing commercial functions, including medical, sales, and marketing, as well as research and development functions, such as clinical, regulatory, and quality.

Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.




Leave a Reply